Syneron seeks buyer for $322m

Shimon Eckhouse
Shimon Eckhouse

Apax Partners is among those interested in the Israeli esthetic medicine company.

Israeli esthetic medicine company Syneron Medical Ltd. (Nasdaq: ELOS) is looking for a buyer. The company has hired Barclays Investment Bank for the task, and Apax Partners is among those interested. Syneron's market cap is $322 million. The company's share price climbed 10% over the past year, but it is still far from the peak it reached more than a decade ago.

It cannot be ruled out that the company will be sold at a price close to $400 million.

The hoped-for acquisition follows the acquisition of two of Syneron's main Israeli competitors, Lumenis and Alma Lasers. Alma Lasers, a private company was sold to China's Fosun Pharma for $240 million, and Lumenis was sold to private equity fund XIO Group for $510 million at a 16% premium on the company's market price at the time.

Return to profitability

Syneron posted $277 million in revenue in 2015 and $215 million in the first nine months of 2016. The company's main problem lies in its profit line. The company formerly made good profits, but posted a $6.4 million loss in 2015, following losses in the preceding years. Syneron made a $1.1 million profit in the first nine months of 2016, with $71 million in revenue in the third quarter, up 15.3%, $24 million of which was accounted for by new products, a 61% increase. Half of the revenue from new products came from a product obtained through the acquisition of Israeli company UltraShape.

Syneron recently obtained approval for its product for treatment of cellulitis, a product regarded as the company's growth engine. Syneron, which has $82 million in cash, is scheduled to publish its annual financial statements in two days. Syneron was founded by Dr. Shimon Eckhouse after he was ousted from Lumenis, which he also founded, by a hostile takeover.

Syneron overtook Lumenis in performance in the 1990s, after which the two companies competed head-to-head while having similar Nasdaq market caps. Lumenis also developed in the direction of the non-esthetic medical market, based on its laser and energy technology. Syneron expanded into other esthetic areas, primarily through acquisitions.

CEO Amit Meridor manages Syneron, while Eckhouse serves as chairman and owns a 7% stake in the company.

Esthetic market no longer Israeli

The medical esthetic market, which has been dominated by Israeli companies since its 1990s boom, is moving into non-Israeli hands (although the Israeli companies are still active). Considerable consolidation has taken place in the field in recent years, with the non-Israeli companies also being acquired or merged - for example Candela, acquired by Syneron itself.

The consolidation process has been spurred by saturation in the core business of esthetic medicine (in hair removal, for example) and intense competition. The past quarter's 51% gross profit margins are nowhere near the margins of 80% or more when the esthetic market began. Non-Israeli competitors have also arisen, such as Cynosure and Lutronic. Younger and smaller companies still remain in Israel, such as EndyMed, Venus Concept, and PerfAction.

Published by Globes [online], Israel Business News - www.globes-online.com - on February 13, 2017

© Copyright of Globes Publisher Itonut (1983) Ltd. 2017

Shimon Eckhouse
Shimon Eckhouse
Emiliano Calemzuk  credit: PR CEO and "investor group" buying out Reshet 13

CEO Emiliano Calemzuk and the other investors will hold 74% of the television channel, while Len Blavatnik’s Access Industries and WBD will remain with 26%.

Inflation  credit: Tali Bogdanovsky Unexpectedly low February CPI reading cuts inflation

While inflation in Israel in the 12 months to the end of February 2025 is lower than forecast, housing prices continue to rise.

Yitzhak Tshuva credit: Gidon Levy and Tali Bogdanovsky Competition Authority allows Delek takeover of Isracard

The Competition Authority is considered the easier of the two regulatory hurdles that the deal must overcome, the other being the Supervisor of Banks.

David Amsalem  credit  Noam Moskowitz, Knesset Spokesperson's Office Rafael to pay state NIS 444m dividend

The minister in charge of the Government Companies Authority, David Amsalem, has approved the payment by the defense company.

Barak MX air defense system  credit: IAI IAI profit jumps 55%

Israel Aerospace Industries posted a net profit of $493 million for 2024, and ended the year with an all-time high orders backlog of $25 billion.

A TSG system in tactical use  credit: PR TSG signs cooperation agreement with US defense co

The agreement includes the integration of TSG's advanced technologies into sensor-based defense systems, which will be integrated into the operational systems of US defense units.

Bria CEO Yair Adato credit: Kseniia Poliak Israeli visual generative AI co Bria raises $40m

Bria’s Visual Generative AI platform empowers businesses to create predictable, controllable, and on-brand content that aligns with their visual language.

Amnon Shashua and Aviram Ziv credit: Eyal Izhar OrCam stymied by investor dispute with Shashua

Demands by institutional investors are blocking the visual and hearing impairment device developer's recovery plan.

Work on the Green Line credit: Bar Lavi Egged wins tender to operate TA light rail Purple, Green Lines

NTA awarded the tender to Egged, which already operates the Red Line, despite government ministry opposition to one operator for the entire network.

Gabi Seroussi illustration: Gil Gibli Board chooses Seroussi as IAI chair as Erdan freezes candidacy

Israel Aerospace Industries board chose Gabi Seroussi as chair even though he did not to go through the preliminary process of the Government Companies Authority appointments review committee.

Bavli Park penthouse credit: Eyal Tagar Tel Aviv Park Bavli penthouse sells for NIS 43m

A 44th floor penthouse in one of the two towers in businessman Yitzhak Tshuva's Park Bavli project has been bought by an Israeli businessperson.

El Al aircraft  credit: Yoav Yaari El Al pilots receive nearly NIS 250,000 bonus each

Thanks to the agreements signed with the unions in 2018, El Al's employees as well as senior management share in last year's success.

Pentera CEO Amitai Ratzon credit: Eyal Izhar Israeli security validation co Pentera raises $60m

Pentera's platform enables security teams to analyze complete attack paths, identify root causes, and prioritize remediation for effective risk reduction.

Tel Aviv credit: Shutterstock Supply of unsold new homes hits record

Israel's real estate market is sliding into recession with 78,000 unsold new apartments in January, the Central Bureau of Statistics reports.

D&B chairman Doron Cohen and Meitar partner Dan Geva Meitar reclaims title of Israel's biggest law firm

Meitar has first place with 537 lawyers, followed by Herzog Fox Neeman with 512 lawyers, according to the latest Dun's 100 rankings.

First International Bank of Israel CEO Eli Cohen  credit: Eyal Toueg First Int'l posts top return on equity

First International Bank of Israel's return on equity in 2024 was 19%, the highest among Israel's banks.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018